1. | theartofbooks | |
2. | fiddledolls67 | |
3. | rjsllewellyn | |
4. | tina | |
5. | kingsnymptonps |
1. | theartofbooks | |
2. | fiddledolls67 | |
3. | rjsllewellyn | |
4. | tina | |
5. | kingsnymptonps |
1. | rjsllewellyn 03/30/2018 Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse® for Treatment of Lambert-Eaton Myasthenic Syndrome |
2. | fiddledolls67 02/12/2018 Announces results of its recent Type C meeting with the FDA |
3. | rjsllewellyn 09/20/2018 Cantor Sees Strong Upside in Catalyst Shares; Sets an $8 Price Target |
4. | theartofbooks 04/24/2018 Catalyst Pharmaceuticals Introduces New Corporate Website |
5. | theartofbooks 02/12/2018 Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse® |
6. | theartofbooks 03/29/2018 Submits New Drug Application to the FDA for Firdapse for the symptomatic treatment of Lambert-Eaton myasthen… |